Publications

Taylor L, Many S, Jeanguenat H, Hattendorf J, Sayasone S, Keiser J. Efficacy and safety of ascending doses of emodepside in comparison with ivermectin in adults infected with Strongyloides stercoralis in Laos: a phase 2a, dose-ranging, randomised, parallel-group, placebo-controlled, single-blind clinical trial. Lancet Infect Dis. 2025(in press). DOI: 10.1016/s1473-3099(25)00255-5

Taylor L, Ahmada A.A, Ali M.S, Ali S.M, Hattendorf J, Mohammed I.S, Keiser J. Efficacy and safety of emodepside compared with albendazole in adolescents and adults with hookworm infection in Pemba Island, Tanzania: a double-blind, superiority, phase 2b, randomised controlled trial. Lancet. 2024;404(10453):683-691. DOI: 10.1016/s0140-6736(24)01403-x

Trippler L, Taylor L, Ali M.N, Najim S.O, Khamis K.S, Hattendorf J, Juma S, Ame S.M, Kabole F, Ali S.M, Knopp S. Test-treat-track-test-treat (5T) approach for Schistosoma haematobium elimination on Pemba Island, Tanzania. BMC Infect Dis. 2024;24:661. DOI: 10.1186/s12879-024-09549-w

Taylor L. Evaluation of different diagnostic tests and strategic approaches for surveillance-response interventions to eliminate Schistosoma haematobium transmission on Pemba Island, Tanzania. Basel: Swiss Tropical and Public Health Institute, 2022. MSc Thesis